A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.
Clinical trial NCT07354022 · RECRUITING
Trial details
- NCT number
- NCT07354022
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-05
- Primary completion
- 2028-12-01
- Enrollment
- 912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.